Rash Completed Phase 2 Trials for Leucovorin (DB00650)

Back to Rash

Also known as: Skin Rash / Rashes / Skin rashes / Rash event / Rash (nonspecific) / Efflorescence / Rash NOS / Rash and other nonspecific skin eruption / Exanthem / Exanthema / Skin eruption / Eruption (disorder) / Eruption (morphologic abnormality) / Eruption

Indication	Status	Phase
DBCOND0019898 (Rash)	Completed	2

clinicaltrials.gov Identifier	Title	Purpose	Drugs
NCT00332163	Skin Toxicity Treatment in Metastatic Colorectal Cancer (mCRC) Patients Receiving Panitumumab + Irinotecan-based Therapy	Treatment	Fluorouracil (DB00544) Irinotecan (DB00762) Leucovorin (DB00650) Panitumumab (DB01269)